Lymphoma, Large B-Cell, Diffuse (DLBCL) Clinical Trials in Beijing, Beijing Municipality

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors